Nasdaq issued three deficiency notices for failing bid price, MVLS, and MVPHS continued listing requirements, threatening delisting.
Instinct Bio Technical Company Holdings Inc. announced it received three separate notifications from the Listing Qualifications Department of The Nasdaq Stock Market LLC on September 9 and September 10, 2026, each flagging a failure to meet a continued listing requirement on The Nasdaq Global Market. On September 9, 2026, Nasdaq notified the company that its market value of listed securities, or MVLS, was below US$50,000,000 from July 28, 2026 through September 8, 2026, putting it out of compliance with Nasdaq Listing Rule 5450(b)(2)(A); Nasdaq also noted the company does not currently satisfy Rule 5450(b)(3)(A). On September 10, 2026, Nasdaq notified the company that its market value of publicly held shares, or MVPHS, was below US$15,000,000 from July 29, 2026 through September 9, 2026, breaching Rules 5450(b)(2)(C) or 5450(b)(3)(C), and separately that the minimum bid price of its ordinary shares was below US$1.00 per share from July 29, 2026 through September 9, 2026, breaching Rule 5450(a)(1). Each notification has no immediate effect on the listing or trading of the company's securities, and each carries a 180-calendar-day compliance period: until March 8, 2027 for the MVLS Requirement and until March 9, 2027 for the MVPHS and Bid Price Requirements. To regain compliance, the company's MVLS must be US$50,000,000 or more and its MVPHS US$15,000,000 or more for a minimum of ten consecutive business days, while its ordinary shares must hold a closing bid price of at least US$1.00 per share for a minimum of 10 consecutive business days, though Nasdaq may require a longer period, generally no more than 20 consecutive business days. Instinct Bio said it is evaluating options to regain compliance with all three requirements and remain listed on Nasdaq, and cautioned there is no guarantee it will successfully regain or maintain compliance with other continued listing requirements during the remediation window.
Nasdaq issued three deficiency notices for failing bid price, MVLS, and MVPHS continued listing requirements, threatening delisting.